Introduction {#s01}
============

Mitotic spindle orientation determines the axis of cell division and plays a key role in cell fate determination in tissues ([@bib29]). Spindle orientation is controlled by forces exerted by cortical dynein--dynactin motor complexes on the astral microtubules emanating from the spindle poles ([@bib6]). The strength of these forces is proportional to the abundance of motor complexes at the cortex ([@bib7]; [@bib17]). In metaphase, dynein--dynactin is recruited via the conserved Gαi--leucine-glycine-asparagine (LGN)--nuclear and mitotic apparatus (NuMA) complex: Gαi, a G protein α subunit, anchors the complex at the plasma membrane, LGN bridges the GDP-bound form of Gαi and the C terminus of NuMA, and NuMA recruits the dynein--dynactin complex to the cortex via its N terminus ([@bib6]). The NuMA--dynein--dynactin complex is also present at spindle poles, where it physically tethers kinetochore fibers to focus the poles ([@bib26]; [@bib11]). In anaphase, additional Gαi/LGN-independent platforms recruit NuMA to the cortex, including the actin-binding protein 4.1R/G and phosphoinositides ([@bib16]; [@bib34]; [@bib19]; [@bib45]).

NuMA recruitment to the cortex must be tightly controlled, as both too little and too much cortical NuMA impairs spindle orientation ([@bib7]; [@bib17]). In metaphase, NuMA phosphorylation by Cdk1 displaces it from the cortex, directing it to spindle poles. When CDK1 activity drops at anaphase onset, the protein phosphatase PP2A dephosphorylates NuMA, resulting in cortical enrichment ([@bib18]; [@bib45]). Conversely, Aurora A phosphorylation directs NuMA to the cortex ([@bib10]; [@bib20]). Finally, the Plk1 kinase displaces LGN and dynein--dynactin when centrosomes or unaligned chromosomes come too close to the cortex ([@bib15]; [@bib35]). This regulation ensures appropriate levels of cortical dynein to orient the spindle in metaphase and to elongate it in anaphase.

Our recent work identified p37, a cofactor of the p97^CDC48^ AAA ATPase, as a regulator of spindle orientation ([@bib21]). p97^CDC48^ regulates multiple processes both in interphase and mitosis. It hydrolyzes ATP to segregate modified substrates from cellular structures, multiprotein complexes, and chromatin, and targets them either to degradation or recycling ([@bib44]). Functional specificity is given by p97 adapters such as p37. How p37 controls spindle orientation is, however, unknown. In this study, we find that p37 ensures proper spindle orientation by preventing the excessive recruitment of NuMA to the cortex in metaphase. Epistasis experiments indicate that p37 acts in a Gαi/LGN-independent manner via the protein phosphatase PP1 and its regulatory subunit Repo-Man, which promote NuMA recruitment to the cortex.

Results and discussion {#s02}
======================

p37 regulates spindle orientation by limiting cortical NuMA levels {#s03}
------------------------------------------------------------------

In tissue culture cells with an intact spindle orientation control, the mitotic spindle is oriented parallel to the growth surface, whereas spindle orientation defects result in a higher median angle between the spindle and the growth surface (called from here on "spindle angle"; [Figs. 1 A](#fig1){ref-type="fig"} and S1 A; [@bib36]). As we previously showed, p37 depletion in HeLa cells increased the spindle angle when compared with control treatment (Fig. S1, A--D; [@bib21]). This effect is rescued by exogenous p37 expression, indicating that this is not a result of an off-target effect ([@bib21]). To understand how p37 controls spindle orientation, we depleted it in HeLa cells, labeled the spindle with SiR-tubulin, a live microtubule marker ([@bib23]), and monitored it by time-lapse imaging. In *siControl* cells, the mitotic spindle remained parallel to the growth substratum and oscillated along the spindle axis ([Fig. 1, A--C](#fig1){ref-type="fig"}). In contrast, in 73% of *sip37* cells, the mitotic spindle exhibited excessive oscillations in all axes, with a mean spindle rotation of 20.5° every 3 min (called spindle rotations from now on; [Fig. 1, A--C](#fig1){ref-type="fig"}; and Fig. S1 B), confirming our previous study ([@bib21]). These orientation defects appeared immediately after mitotic entry, implying that they were not caused by a prolonged mitotic arrest, in contrast with other protein depletions that only deregulate spindle orientation several hours into a mitotic arrest ([@bib35]).

![**p37 regulates spindle orientation by limiting cortical NuMA levels. (A)** Time-lapse images of *siControl* and *sip37* HeLa cells stained with SiR-tubulin (live microtubule marker). Red dashed lines indicate the metaphase plate position. Unless otherwise stated, analyses were performed on metaphase cells throughout the paper. *t* = 0 was set at the first image with a bipolar spindle. **(B)** Schematics of cells with WT spindle movements (top) and excessive spindle rotations (bottom). Black arrows indicate spindle movements. **(C)** Mean percentages of cells with excessive spindle rotations (when on average the spindle rotates \>10° per 3-min time point). *n* = 3 independent experiments; *n* = 83--96 cells. \*\*, P = 0.0077 in a paired *t* test. **(D)** Schematics representing the ternary complex that generates forces on microtubules. **(E)** Confocal images of *siControl* and *sip37* cells immunostained for α-tubulin (microtubules), γ-tubulin (spindle poles), Gαi, LGN, NuMA, or p150^glued^, as indicated. White arrows point to the cortical localization of these proteins. **(F)** Quantification of mean cortical intensities of Gαi, LGN, NuMA, and p150^glued^ in p37-depleted cells normalized to *siControl* (dashed line). *n* = 4--5; *n* = 74--140 cells. P \< 0.0001 in a one-way ANOVA test; \*\*, P \< 0.01 versus control. **(G)** Quantification of cytoplasmic and cortical NuMA levels in *siControl* and *sip37* cells. The quantification is shown as a line profile representing the mean intensity across the cortex. *n* = 4; *n* = 86--87. The cortex is at the border between the cytoplasm (dark gray) and the extracellular environment (light gray). **(H)** Quantification of spindle pole NuMA volume in cells with the indicated depletions. *n* = 3; spindle poles = 120--159. \*\*\*\*, P \< 0.0001 in an unpaired *t* test. **(I)** Mean intensity profile of cortical NuMA along the entire cortex relative to the spindle (x and y axis) in *siControl* (black) and *sip37* cells (red). *n* = 3; *n* = 79--85. **(J)** Western blot of mitotic cell lysates treated with indicated siRNAs and probed against NuMA and α-tubulin (loading control). **(K)** Quantification of NuMA/α-tubulin ratio signal in three Western blots as shown in J in *siControl* and *sip37* cell extracts. **(L)** Quantification of spindle angles in *siControl* and *sip37* fixed cells stained against γ-tubulin as shown in Fig. S3 A. Data are shown as box plots. Each point represents a cell; + indicates the mean spindle angle. *n* = 4; *n* = 57--75 cells. \*\*, P \< 0.01 in a Kruskal-Wallis test. **(M)** Mean percentages of HeLa--dynein heavy chain--GFP cells with spindle rotations after indicated siRNAs. *n* = 3; *n* = 50--59 cells. Error bars indicate SEM (C, F, I, K, and M) or SD (H). \*\*, P = 0.0093 in a one-way ANOVA test. **(N)** Western blot against lysates of cells treated with indicated siRNAs and probed with NuMA, α-tubulin, and p37 antibodies. Bars, 10 µm.](JCB_201707050_Fig1){#fig1}

These excessive spindle rotations were similar to the ones observed in cells overexpressing Gαi, LGN, or NuMA ([Fig. 1 D](#fig1){ref-type="fig"}; [@bib7]; [@bib17]). We therefore immunostained *siControl* and *sip37* cells against Gαi, LGN, NuMA, and p150^glued^ (a dynein--dynactin subunit) and quantified their levels at the cortex. Both p150^glued^ and NuMA levels were increased by 50% in *sip37* cells, whereas Gαi and LGN levels were unchanged ([Fig. 1, E and F](#fig1){ref-type="fig"}). NuMA has a complex localization pattern, as it forms large crescents at spindle poles and is present in the cytoplasm and the cortex ([Fig. 1 E](#fig1){ref-type="fig"}). At the cortex, NuMA is enriched proximal to spindle poles and is displaced from regions close to the chromatin via the Ran-GTP gradient ([Fig. 1 E](#fig1){ref-type="fig"}; [@bib15]; [@bib1]). We used line profiles in *siControl* and *sip37* cells to quantify cortical and cytoplasmic NuMA levels and a threshold function to measure the volume it occupies at spindle poles (Fig. S3, D--F). p37 depletion increased cortical NuMA levels by 48% and in the cytoplasm by 22% ([Fig. 1 G](#fig1){ref-type="fig"}) but decreased the volume of NuMA spindle pole crescents by 41% ([Fig. 1 H](#fig1){ref-type="fig"}). The increase in cortical levels did not reflect a disruption of local regulation, as NuMA was still enriched proximal to the spindle poles ([Fig. 1 I](#fig1){ref-type="fig"}). Immunoblotting of *siControl* and *sip37* cell extracts revealed constant total cellular NuMA levels ([Fig. 1, J and K](#fig1){ref-type="fig"}), indicating that p37 specifically regulates NuMA localization. The increase in cortical NuMA levels was responsible for the spindle orientation defects, as partial NuMA codepletion restored normal spindle angles ([Fig. 1 L](#fig1){ref-type="fig"}) and suppressed the excessive spindle rotations ([Fig. 1 M](#fig1){ref-type="fig"}) in *sip37* cells; it did not, however, change the spindle angle in *siControl* cells. This rescue was not caused by an RNAi competition effect because p37 was depleted to the same extent whether NuMA was codepleted or not ([Fig. 1 N](#fig1){ref-type="fig"}). We conclude that p37 controls spindle orientation by limiting the amount of cortical NuMA in metaphase.

High cortical NuMA levels in *sip37* cells depend on a protein phosphatase activity {#s04}
-----------------------------------------------------------------------------------

p37 depletion did not affect cortical Gαi and LGN levels, but it increased cortical NuMA levels, suggesting a Gαi-independent recruitment. To test this hypothesis, we codepleted Gαi and p37. Gαi depletion abolished cortical NuMA in control metaphase cells as previously shown ([Fig. 2, A--C](#fig2){ref-type="fig"}; [@bib42]), but it left a cortical NuMA pool in *sip37* cells ([Fig. 2, A and B](#fig2){ref-type="fig"}). Equivalent results were observed after LGN depletion (Fig. S1, E--H), implying that a pool of cortical NuMA in *sip37* cells is recruited in a Gαi/LGN-independent manner.

![**High cortical NuMA levels in p37-depleted cells depend on a phosphatase but are independent of Gαi or Aurora A. (A--C)** Confocal images of HeLa cells stained for Gαi and NuMA (A) and corresponding cortical NuMA (B) and Gαi (C) line profiles in the indicated depletions. All line profiles represent the mean intensity across the cortex. *n* = 4--5; *n* = 72--112 cells. **(D)** Schematic representation of the regulation of NuMA localization by protein phosphorylation or dephosphorylation. **(E and F)** Confocal images of cells after indicated depletions and DMSO (0.01%) or MLN8237 (20 nM at 24 h) treatments stained for phospho-Aurora A (pT288) and α-tubulin (E) and corresponding quantification of centrosomal pT288--Aurora A (F). *n* = 2; *n* = 31--47. **(G and H)** The same cells as in E and F but stained for α-tubulin and NuMA (G) and corresponding cortical NuMA line profiles (H). *n* = 4; *n* = 80--97 cells. **(I and J)** Confocal images of cells stained for α-tubulin and NuMA after indicated depletions and DMSO (0.01%) or calyculin A (50 nM for 10 min) treatments (I) and corresponding cortical NuMA line profiles (J). *n* = 3; *n* = 59--65 cells. Error bars indicate SD. Bars, 10 µm.](JCB_201707050_Fig2){#fig2}

Aurora A phosphorylates NuMA in metaphase to promote its cortical enrichment ([Fig. 2 D](#fig2){ref-type="fig"}; [@bib10]; [@bib20]). Because p37 depletion increases the centrosomal levels of Aurora A in prophase ([@bib21]), we tested whether the increase in cortical NuMA levels depended on Aurora A. We inhibited Aurora A activity in *siControl* and *sip37* cells using 20 nM MLN8237 for 24 h and then quantified cortical NuMA levels. This treatment impaired Aurora A activity, as assessed by phospho-T288 antibodies recognizing active Aurora A, and severely reduced cortical NuMA levels ([Fig. 2, E--H](#fig2){ref-type="fig"}). Nonetheless, p37 depletion still increased cortical NuMA in MLN8237-treated cells, indicating that p37 can regulate NuMA independently of Aurora A ([Fig. 2, G and H](#fig2){ref-type="fig"}).

Phosphorylation by Cdk1 negatively regulates NuMA cortical localization, whereas dephosphorylation by PP2A promotes it ([Fig. 2 D](#fig2){ref-type="fig"}; [@bib18]; [@bib45]). High cortical levels of NuMA in *sip37* are unlikely to be a result of low Cdk1 activity because *sip37* cells enter mitosis with no significant delay (unpublished data) and show no changes in the levels of epitopes stained by MPM2, a phosphoantibody that recognizes Cdk1 phosphorylation targets (Fig. S1, I and J; [@bib41]). To test the involvement of a phosphatase, we treated *sip37* cells with the phosphatase inhibitor calyculin A (50 nM for 10 min). As previously shown, this treatment prevented cortical NuMA recruitment in *siControl* cells ([@bib18]). It also abolished the increase in cortical NuMA levels seen after p37 siRNA ([Fig. 2, I and J](#fig2){ref-type="fig"}) but did not alter the cortical Gαi and LGN levels (Fig. S1, K and L). We conclude that p37 limits cortical NuMA levels by preventing the action of a phosphatase.

p37 regulates NuMA levels via PP1 {#s05}
---------------------------------

We next asked whether p37 regulates cortical NuMA levels via PP2A. As shown previously, PP2A depletion abolished cortical NuMA localization in *siControl* cells ([@bib18]); it did not, however, suppress the increase in cortical NuMA levels in *sip37* cells ([Fig. 3, A--C](#fig3){ref-type="fig"}). This suggests that PP2A is not the main phosphatase through which p37 regulates cortical NuMA levels. Calyculin A inhibits both PP2A and PP1 ([@bib14]). Because exogenous p37 efficiently pulls down the PP1 isoform PP1α ([@bib32]), we tested whether codepletion of the catalytic PP1α subunit impairs the excessive cortical recruitment of NuMA. PP1α depletion left cortical NuMA levels unchanged in control cells but abolished the excessive NuMA recruitment in *sip37* cells ([Fig. 3, D--F](#fig3){ref-type="fig"}) and restored normal spindle angles (median of 15.6° in *siControl/sip37*-treated cells versus 8.0° in *sipp1α/sip37* cells; [Fig. 3 G](#fig3){ref-type="fig"}). We conclude that p37 regulates cortical NuMA abundance via PP1.

![**p37 regulates cortical NuMA levels via PP1. (A and B)** Confocal images of HeLa cells stained for α-tubulin and NuMA after indicated depletions (A) and corresponding cortical NuMA line profiles (B). All line profiles represent the mean intensity across the cortex. *n* = 5; *n* = 109--112 cells. **(C)** Western blot of lysates of cells treated with indicated siRNAs and probed with p37, PP2a, and p97 (loading control) antibodies. **(D and E)** Confocal images of cells stained for α-tubulin and NuMA after indicated depletions (D) and corresponding cortical NuMA line profiles (E). *n* = 4; *n* = 102--104 cells. **(F)** Western blot of lysates of cells treated with indicated siRNAs and probed with p37, PP1ac, and p97 antibodies. The p37 and PP1ac immunoblots were run separately. **(G)** Quantification of spindle angles in cells treated with indicated siRNAs and stained with α-tubulin as in [Fig. 1](#fig1){ref-type="fig"}. *n* = 3; *n* = 73--85 cells. \*\*\*\*, P \< 0.0001 in a Kruskal-Wallis test. **(H and I)** Confocal images of cells transfected with GFP-NuMA and GFP-NuMA (T2055E) stained with DAPI after indicated depletions (H) and corresponding normalized GFP-NuMA line profiles (I). *n* = 3; *n* = 45--56 cells. **(J and K)** Confocal images of *siControl* and *sip37* HeLa GFP-PP1α cells (J) and corresponding quantifications of GFP-PP1α levels at kinetochores (K). *n* = 3; *n* = 621--730. \*\*\*\*, P \< 0.0001 in unpaired *t* tests. Bars, 10 µm.](JCB_201707050_Fig3){#fig3}

Cdk1 and PP2A regulate NuMA in metaphase via threonine 2055 at the C terminus ([@bib18]; [@bib34]; [@bib45]). To test whether p37 regulates NuMA via the same site, we asked whether its depletion affects the localization of a phosphomimetic T2055E NuMA mutant. As previously shown, cortical GFP-NuMA-T2055E levels were reduced compared with GFP-NuMA in control depleted cells ([@bib18]), but in *sip37* cells, they were comparable, indicating that p37 regulates NuMA via a pathway that is separate from the one controlled by Cdk1 and PP2A ([Fig. 3, H and I](#fig3){ref-type="fig"}).

Our results infer that the excessive cortical NuMA levels observed in *sip37* cells are caused by high PP1 activity. PP1 activity could be generally higher in *sip37* cells, or p37 could spatially regulate PP1 activity. In metaphase, PP1α is enriched at kinetochores, where it stabilizes kinetochore--microtubule attachments and silences the spindle assembly checkpoint by dephosphorylating Aurora B kinase and its substrates ([@bib28]; [@bib30]; [@bib40]; [@bib22]). When we compared PP1α levels at kinetochores in HeLa cells stably expressing GFP-PP1α, we found a significant reduction in *sip37* cells ([Fig. 3, J and K](#fig3){ref-type="fig"}). We also observed higher phospho--Aurora B (T232) levels on metaphase chromosomes, whereas Aurora B levels were unchanged (Fig. S2, A--D), consistent with lower PP1 activity. We conclude that p37 depletion does not lead to a generally higher PP1 activity in metaphase. We instead postulate that it leads to a lower PP1 activity at kinetochores and a higher cytoplasmic activity that promotes cortical NuMA localization.

PP1/Repo-Man controls cortical NuMA localization in metaphase {#s06}
-------------------------------------------------------------

PP1 phosphatases are composed by a catalytic and a regulatory subunit. In human cells, there are ∼200 regulatory subunits each influencing PP1 localization, substrate specificity, and activity ([@bib3]). The two best-characterized mitotic regulatory PP1 subunits are Sds22 and Repo-Man ([@bib37]; [@bib39]; [@bib31]; [@bib43]; [@bib9]; [@bib33]). We codepleted either of them in *siControl* or *sip37* cells and measured cortical NuMA levels. Whereas Sds-22 depletion had no effect, depletion of Repo-Man abolished cortical NuMA enrichment both in *siControl* and *sip37* metaphase cells ([Fig. 4, A--D](#fig4){ref-type="fig"}; and Fig. S2, E and F), whereas it left Gαi and LGN levels unchanged (Fig. S2, G--J). This effect was not a result of an off-target effect, as a second validated Repo-Man siRNA also impaired cortical NuMA recruitment (Fig. S2 K; [@bib43]). To validate that PP1/Repo-Man positively regulates NuMA localization at the cortex, we transiently overexpressed eGFP--Repo-Man or a mutant that cannot bind PP1, eGFP--Repo-Man^RAXA^ ([@bib37]), and monitored cortical NuMA levels and spindle orientation. eGFP--Repo-Man expression led to higher cortical NuMA levels than eGFP expression, whereas eGFP--Repo-Man^RAXA^ expression led to lower levels ([Fig. 4, E and F](#fig4){ref-type="fig"}). 63% of the cells expressing eGFP--Repo-Man but only 27% of the cells expressing eGFP--Repo-Man^RAXA^ and 13% of untransfected cells also showed excessive spindle rotations ([Figs. 1](#fig1){ref-type="fig"} and [4, G and H](#fig4){ref-type="fig"}). These excessive spindle rotations depended on NuMA because partial NuMA depletion suppressed this percentage to 29% in eGFP--Repo-Man--expressing cells ([Fig. 4, I and J](#fig4){ref-type="fig"}). We conclude that PP1/Repo-Man activity is essential for cortical recruitment of NuMA in metaphase and that p37 must restrain this activity to prevent spindle orientation defects caused by excessive cortical recruitment of NuMA.

![**PP1/Repo-Man controls cortical NuMA localization in metaphase. (A--D)** Confocal images of HeLa cells treated with indicated depletions and immunostained for NuMA and α-tubulin (A and C) and corresponding NuMA line profiles (B and D). All line profiles represent the mean intensity across the cortex. *n* = 3--4; *n* = 52--77 cells. **(E and F)** Confocal images of cells transiently expressing eGFP--Repo-Man, eGFP--Repo-Man^RAXA^, or eGFP stained with NuMA antibodies and DAPI (DNA; E) and corresponding NuMA line profiles (F). *n* = 3; *n* = 49 cells. **(G)** Time-lapse images of metaphase HeLa cells transiently expressing eGFP--Repo-Man or eGFP--Repo-Man^RAXA^. *t* = 0 min is set at the time of chromosome alignment. Red dashed lines indicate positions of metaphase plates, and dashed red circles indicate metaphase plates rotated by 90° in the z axis. **(H)** Mean percentage of transfected cells with spindle rotations. *n* = 4; *n* = 42--58 cells. \*, P = 0.0128 in paired ratio *t* test. **(I)** Time-lapse images of metaphase cells transiently expressing eGFP--Repo-Man treated with control or NuMA siRNA and labeled as in G. **(J)** Mean percentages of transfected cells with spindle rotations. *n* = 5; *n* = 32--34 cells. \*, P = 0.0140 in a paired ratio *t* test. Error bars indicate SEM. Bars, 10 µm.](JCB_201707050_Fig4){#fig4}

p37 controls the PP1/Repo-Man--NuMA pathway specifically in metaphase {#s07}
---------------------------------------------------------------------

Cortical NuMA levels are temporally regulated as new Gαi-independent populations of NuMA are recruited to the cortex once cells enter anaphase ([@bib16]; [@bib34]; [@bib19]). We thus investigated whether Repo-Man or p37 depletion also affect NuMA localization in anaphase ([Fig. 5, A and B](#fig5){ref-type="fig"}). Repo-Man depletion decreased cortical NuMA levels in anaphase. In contrast, *sip37* did not affect NuMA levels in anaphase. This indicates that PP1/Repo-Man activity positively regulates cortical NuMA in metaphase and anaphase and that p37 limits this activity specifically in metaphase.

![**p37 controls the PP1/Repo-Man--NuMA pathway specifically in metaphase. (A)** Confocal images of anaphase HeLa cells treated with indicated siRNAs and stained with NuMA antibodies and DAPI (DNA). Bars, 10 µm. **(B)** The corresponding NuMA line profile represents the mean intensity across the cortex. *n* = 3; *n* = 76--80 cells. **(C)** Working model: p37 negatively regulates PP1/Repo-Man to limit cortical NuMA in metaphase.](JCB_201707050_Fig5){#fig5}

Our results identify a novel regulatory pathway controlling the abundance of the NuMA--dynein motor complex at the cortex ([Fig. 5 C](#fig5){ref-type="fig"}): PP1/Repo-Man promote NuMA localization at the cortex but are kept in check by p37 until anaphase. A failure to do so leads to severe spindle orientation defects in metaphase as a result of excessive dynein-dependent forces. This argues that the PP1/Repo-Man complex has a more general role than just acting at kinetochores and/or chromatin, unlike what is currently thought. We further postulate that in anaphase, PP1 promotes recruitment of NuMA at the cortex in conjunction with PP2A. Future investigations will uncover how PP1/Repo-Man controls NuMA. NuMA has a PP1 binding motif (RVxF; [@bib8]), and mass spectroscopy analysis of PP1 immunoprecipitates identified NuMA ([@bib27]), suggesting a direct interaction. In all our experiments, Repo-Man depletion had a stronger effect on NuMA than PP1α depletion, suggesting that Repo-Man might regulate NuMA in combination with several PP1 isoforms. A second important aspect of future investigation is the relationship between p37 and PP1/Repo-Man. Our data point to a local regulation as we find lower PP1 activity at kinetochores and higher NuMA levels at the cortex. We speculate that p37 mobilizes PP1/Repo-Man from cytoplasmic complexes in metaphase, allowing it to bind to kinetochores and chromatin. When p37 levels are low, high cytoplasmic PP1/Repo-Man activity dephosphorylates NuMA, which leads to higher cytoplasmic and cortical NuMA levels. This model is compatible with proteomic studies, which reported interactions between several PP1 subunits and p37 ([@bib12], [@bib13]; [@bib32]). Moreover, Shp1, the *Saccharomyces cerevisiae* orthologue of p37, positively regulates nuclear accumulation of yeast PP1 (called Glc7) to promote Glc7 activity at kinetochores ([@bib5]; [@bib2]), suggesting that the overall principle of the pathway is conserved.

Materials and methods {#s08}
=====================

Cell culture methods and drug treatments {#s09}
----------------------------------------

HeLa Kyoto cells and HeLa dynein heavy chain--GFP cells (gift from I. Cheeseman, Massachusetts Institute of Technology, Cambridge, MA) were grown in DMEM containing 10% FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C with 5% CO~2~ in a humidified incubator. HeLa eGFP-centrin1/eGFP--CENP-A cells were supplemented with 0.2 mg/ml of G418 and 0.5 µg/ml of puromycin. HeLa GFP-PP1α cells (GA4.3; gift from L. Trinkle-Mulcahy; [@bib37]) were supplemented with 0.4 mg/ml of G418. Live-cell imaging experiments were performed at 37°C in Lab-TekII (Thermo Fisher Scientific) and Ibidi chambers in Leibovitz's medium (L15) supplemented with 10% FCS. For drug treatments, Aurora A was inhibited for 24 h with 20 nM MLN8237 (Selleckchem) and PP1/PP2A for 10 min with 50 µM calyculin A (Thermo Fisher Scientific; [@bib14]). To visualize microtubules during live-cell imaging, 50 nM SiR-tubulin (Spirochrome AG) was added to the cells 3 h before acquisition. To synchronize HeLa cells in mitosis, cells were treated for 14 h with 20 µM of the Eg5 inhibitor (+)-*S*-Trityl-[l]{.smallcaps}-cysteine (Sigma-Aldrich).

siRNA and plasmid transfections {#s10}
-------------------------------

The siRNA oligonucleotides used for protein depletions (Thermo Fisher Scientific, GE Healthcare, or QIAGEN) were all already validated by other laboratories (references cited for each siRNA) and are as follows: control (scrambled, 5′-GGACCUGGAGGUCUGCUGU-3′; [@bib25]), p37 (5′-CUCCAGAAGAGGAGGAUAA-3′; [@bib38]), NuMA (5′-GGCGUGGCAGGAGAG-3′; [@bib16]), Gαi~1/3~ (5′-CCGAAUGCAUGAAAGCAUG-3′; [@bib16]), Gαi~2~ (5′-CUUGAGCGCCUAUGACUUG-3′; [@bib16]), LGN (SMARTpool, 5′-GAACUAACAGCACGACUUA-3′, 5′-CUUCAGGGAUGCAGUUAUA-3′, 5′-ACAGUGAAAUUCUUGCUAA-3′, and 5′-UGAAGGGUUCUUUGACUUA-3′; [@bib15]), PP1αc (5′-CCGCAATTCCGCCAAAGCCAA-3′; [@bib43]), PP2Ac (5′-ATGGAACTTGACGATACTCTA-3′; [@bib18]), Repo-Man (5′-ATGGGACTCATCCGAGCTTAA-3′ in all figures except Fig. S2 and 5′-AGCAAATACTCCATTGCGTAA-3′ in Fig. S2; [@bib43]), and Sds22 (5′-AGAGTTCTGGATGAACGACAA-3′; [@bib43]). Cells were transfected with siRNAs for 48 h unless otherwise indicated at final concentrations of 50 nM using Lipofectamine RNAiMAX (Thermo Fisher Scientific). For codepletion experiments, selected siRNA oligonucleotides were transfected at a 1:1 ratio with a total concentration of 50 nM. For gene expression, the following plasmids were used: pEGFP-C1 (Invitrogen), pEGFP-(C1)--Repo-Man, and pEGFP-(C1)--Repo-Man/RAXA (gift from A. Lamond; plasmids 44212 and 44213; Addgene [@bib37]), GFP-NuMA-FL, and GFP-NuMA-T2055E (gift from P. Gönzcy; [@bib18]). Cells were transfected with 0.5--2 µg of plasmid DNA using Lipofectamine 2000 (Invitrogen) and analyzed 24 h after transfection. For experiments involving siRNA and plasmid DNA transfection, the siRNA and DNA were added to the cells 48 and 24 h before analysis, respectively.

Immunofluorescence {#s11}
------------------

Cells were fixed with 4% formaldehyde/0.2% glutaraldehyde (in PBS) for 15 min at room temperature. Slides were washed for 5 min with PBS/NH~4~Cl (50 mM), washed twice with PBS, and incubated overnight with primary antibodies diluted in permeabilization buffer (20 mM Pipes, 0.5% saponin, 5% BSA, 137 mM NaCl, and 2.7 mM KCl, pH 6.8) at 4°C in a wet chamber. The slides were washed, incubated at room temperature with secondary antibodies diluted in permeabilization buffer for 45 min, and mounted on Vectashield with DAPI (Vector Laboratories). For immunofluorescence of HeLa GFP-PP1α (GA4.3), cells were fixed with 4% formaldehyde and 0.1% Triton X-100, and then slides were washed with PBS and mounted on Vectashield with DAPI. Alternatively, cells were fixed with methanol at −20°C for 4 min, washed with PBS, blocked for 1 h with 1% PBS/BSA, and incubated overnight with primary antibodies (in PBS/1% BSA) at 4°C in a wet chamber. After PBS washes, slides were incubated with secondary antibodies (in PBS/1% BSA) for 45 min at room temperature, washed with PBS, and mounted on Vectashield with DAPI. The following primary antibodies were used: anti-NuMA (rabbit; 1:500; Abcam), anti-Gαi (mouse; 1:200; Santa Cruz Biotechnology, Inc.), anti-p150^glued^ (mouse; 1:400; BD), anti--Aurora B (rabbit; 1:1,000; [@bib24]), antiphospho--Aurora B T232 (rabbit; 1:1,000; Rockland Inc.), antiphospho--Aurora A T288 (rabbit; 1:1,500; Cell Signaling Technology), anti--α-tubulin (mouse; 1:1,000; Sigma-Aldrich), anti--γ-tubulin (rabbit; 1:1,000; Sigma-Aldrich), anti-MPM2 (mitotic proteins; mouse; 1:1,000; Abcam), and anti-LGN (rabbit; 1:400; Sigma-Aldrich). For secondary antibodies, cross-adsorbed Alexa Fluor--conjugated antibodies (1:400; Invitrogen) were used.

Image acquisition, live-cell imaging, and image quantification {#s12}
--------------------------------------------------------------

Images for immunofluorescence were acquired using either an A1r spectral confocal microscope (Nikon) or an LSM800 Airyscan confocal microscope (ZEISS). The A1r spectral (inverted T*i* Eclipse) confocal microscope is equipped with four PMTs, including two highly sensitive detectors (GaAsP) for green and red channels. Experiments were performed with a 60× 1.4 NA CFI Plan Apochromat Lambda oil objective, and NIS Elements AR software (v.4.20.01; Nikon) was used to set acquisition parameters. The LSM800 Airyscan confocal microscope was equipped with two high-sensitive GaAsP photomultiplier tube detectors. Experiments were performed with a Plan Apochromat 63× 1.40 NA oil objective, and ZEN software (v.2.3; ZEISS) was used to set acquisition parameters. Live-cell imaging was performed for 8--12 h at 37°C on the T*i* widefield microscope (Nikon) equipped with an environmental chamber using a 60× 1.3 NA oil objective and a CoolSNAP HQ camera (Roper Scientific) at a sampling rate of 3 min, recording at each time point of 12 z stacks separated by 1 µm using NIS Elements AR software. The recorded images were quantified using FIJI software (ImageJ; National Institutes of Health) and Imaris (7.7.1; Bitplane). TIFF or PNG images were mounted into figures using CS Photoshop and CS Illustrator (Adobe).

The spindle rotation phenotype was scored in time-lapse videos by analyzing mean changes in angle/position of the metaphase spindle over time through live-cell imaging. To determine the spindle angle in fixed metaphase cells, cells were stained for γ- or α-tubulin. The x, y, and z coordinates of the spindle poles were obtained, and the spindle angle was calculated by applying the spindle pole coordinates to the trigonometric function shown in Fig. S3 A. The levels of cortical protein were measured by overlaying a 3-pixel-wide line on the cortex of a metaphase cell to obtain the mean intensity (Fig. S3 B). To quantify chromosomal Aurora B and phosphor--T232 Aurora B in metaphase, the DAPI image was used to build a mask for measuring the mean intensity value of the fluorescence signal on chromatin, and the same mask was used to correct for background (Fig. S3 C). To obtain the line profile of cortical proteins, a 10-pixel-wide × 6-µm-long line scan overlapping the cortex was used (Fig. S3 D). The line profiles of individual cells were first averaged within an experiment before calculating the mean between experiments. To quantify cortical NuMA levels around the entire cortex, we generated an intensity profile in metaphase using ImageJ (Fig. S3 E). To obtain the volume of NuMA at spindle poles, we applied a threshold function to the immunofluorescence images and performed the measurement using Imaris software (Fig. S3 F). To quantify GFP-PP1α at kinetochores, we determined the ratio between GFP signal intensities at kinetochores and normalized it with the cytoplasmic GFP signal (Fig. S3 G).

Western blotting {#s13}
----------------

For cell extracts, cells were harvested in lysis buffer (150 mM KCl, 50 mM Tris, pH 7.4, 5 mM MgCl~2~, 5% glycerol, 1% Triton X-100, 2 mM β-mercaptoethanol supplemented with EDTA-free protease inhibitor, and PhosSTOP phosphatase inhibitor \[Roche\]) and incubated on ice for 1 h. After centrifugation for 20 min at 13,000 rpm, the protein concentration in the supernatant was determined in a Bradford assay (Bio-Rad Laboratories) using a UV/Vis Spectrophotomer (MicroDigital). Alternatively, to quantify total NuMA levels, cells were directly harvested in Laemmli sample buffer and boiled for 10 min before mechanical shearing through a 26G syringe tip. The following primary antibodies were used: anti-NuMA (rabbit; 1:1,000; Abcam), anti-PP2Ac (rabbit; 1:1,000; EMD Millipore), anti-PP1αc (rabbit; 1:1,000; Cell Signaling Technology), anti-p97 (rabbit; 1:1.000; a gift from H. Meyer; [@bib4]), anti-p37 (rabbit; 1.15 µg/µl; this study), and anti--Repo-Man (rabbit; 1:2,000; Cell Signaling Technology). The following HRP-conjugated secondary antibodies were used: ECL anti--rabbit IgG (GE Healthcare) and anti--mouse IgG (Bio-Rad Laboratories). Proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes by wet blotting. Protein bands were detected using the ECL Prime Western Blotting Detection reagent (GE Healthcare) and a PXi/PXi Touch luminescence detector (Syngene). Protein bands were quantified with ImageJ as described in the method outlined at <http://lukemiller.org/index.php/2010/11/-analyzing-gels-and-western-blots-with-image-j/>.

Antibody production {#s14}
-------------------

The full-length p37 cDNA was subcloned by Gateway technology (Invitrogen) into the pDEST--maltose-binding protein (MBP) vector. Recombinant MBP-tagged p37 (MBP-p37) protein expression was induced in BL21 *Escherichia coli* and purified using standard column purification on an amylose resin (New England Biolabs, Inc.) column. Purified MBP-p37 was used to immunize two rabbits with a standard immunization protocol (Moravian-Biotechnology). The anti-p37 serum was affinity purified on membrane strips carrying bacterially expressed GST-p37 antigen.

Statistical methods {#s15}
-------------------

Outliers in fluorescent intensity quantifications were determined and removed from data using the modified Thompson Tau method. Paired two-tailed *t* tests, one-way ANOVA tests, Mann-Whitney tests, and Kruskal-Wallis tests were run on PRISM (7.02; GraphPad Software). Graphs were plotted in PRISM and mounted in Illustrator. Box blots show median, lower, and upper quartiles (line and box), 10th and 90th percentiles (whiskers), and means (+).

Online supplemental material {#s16}
----------------------------

Fig. S1 is related to [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} and shows quantification of spindle angle in p37-depleted cells, characterization of spindle rotation, characterization of the p37 antibody, cortical LGN and NuMA levels in LGN and LGN/p37 depletions, MPM2 data, and levels of Gαi and LGN in control and calyculin A--treated cells. Fig. S2 is related to [Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"} and shows chromosomal Aurora B and phospho--T232 Aurora B levels in p37-depleted cells, Western blotting of the lysates of controls and the codepletion of Sds-22 and Repo-Man with p37, corresponding quantifications and Gαi and LGN staining in the Repo-Man and Repo-Man/p37 depletions, and NuMA line profile after depletion of Repo-Man with a second independent siRNA. Fig. S3 is related to the Image acquisition, live-cell imaging, and image quantification section of the Materials and methods and illustrates how the data presented in the manuscript were quantified.
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